
Aspan Pharma Private Limited
About Aspan Pharma Private Limited
Data last updated:
Aspan Pharma Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 13 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21001MH2023PTC402890.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashutosh Suresh Gokhale and Aaliya Younus Naik.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.04 Cr, a growth of 134% compared to the previous year. For the same year it recorded a net profit of ₹4.72 Lakh (net margin 2.3%) and EBITDA of ₹6.38 Lakh (EBITDA margin 3.1%).
Company details
Contact details
Aspan Pharma Private Limited's registered office is in Kalyan, Maharashtra.
- Registered AddressRe A – 19 MIDC Res Zone, Near Dombivali Gymkhana, Kalyan, Maharashtra, India – 421201
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aspan Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Aspan Pharma Private Limited, buy the company report.
Financials of Aspan Pharma Private Limited
FY 2025 filings availableAspan Pharma Private Limited reported revenue of ₹2.04 Cr (up 134% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 134% in the latest year. EBITDA rose 113% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹6.38 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹4.72 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.1% | |
| Net Profit Margin | 2.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Aspan Pharma Private Limited, buy the company report.
Board of directors of Aspan Pharma Private Limited
Aspan Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Suresh Gokhale | Director | 13 May 2023 | 3 Years 5 Months | Current |
| Aaliya Younus Naik | Director | 13 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Aspan Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ekvira Fine-Chem Pvt Ltd | ₹2.08 Cr (FY 2025) | -12.0% | Raigad, Maharashtra, India | |||
| Limelush Organics Private Limited | ₹2.08 Cr (FY 2025) | 524.0% | Anekal, Karnataka, India | |||
| Mudraa Agrochemicals Private Limited | ₹2.08 Cr (FY 2025) | 261.0% | Guntur, Andhra Pradesh, India | |||
| Soilfit Agriscience Private Limited | ₹2.04 Cr (FY 2025) | 100.0% | Coimbatore, Tamil Nadu, India | |||
| Amaze Healthcare Private Limited | ₹2.04 Cr (FY 2025) | 21.0% | Miraj, Maharashtra, India | |||
| Aspan Pharma Private Limitedthis company | ₹2.04 Cr (FY 2025) | ₹4.72 Lakh | 2.3% | 134.0% | Kalyan, Maharashtra, India | |
| Sunwest Bio Medical Private Limited | ₹2.02 Cr (FY 2024) | Gurugram, Haryana, India | ||||
| Samnee Life Sciences Private Limited | ₹2.01 Cr (FY 2025) | -11.0% | Kandivlai West, Maharashtra, India | |||
| Uke Engineering Private Limited | ₹2.01 Cr (FY 2025) | 18.0% | Gurgaon, Haryana, India | |||
| Isoflex Adhesive Private Limited | ₹2.01 Cr (FY 2025) | 140.0% | Ramgarh, Rajasthan, India | |||
| Selexia Biotech Private Limited | ₹2 Cr (FY 2025) | 13.0% | Delhi, India |
To see the full peer comparison of Aspan Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aspan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aspan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aspan Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aspan Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Aaliya Younus Naik was appointed as Director on 13 May 2023.
Frequently asked questions
Aspan Pharma is an active private limited company based in Kalyan, Maharashtra, India. The company works in paper and paper products, within the paper industry. It was incorporated on 13 May 2023 (3+ years old) and is registered under CIN U21001MH2023PTC402890.
Aspan Pharma has 2 current directors:
- Ashutosh Suresh Gokhale - Director
- Aaliya Younus Naik - Director
The latest financial statements of Aspan Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Aspan Pharma is U21001MH2023PTC402890. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aspan Pharma was incorporated on 13 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aspan Pharma by revenue are Ekvira Fine-Chem Pvt Ltd, Limelush Organics Private Limited, Mudraa Agrochemicals Private Limited, Soilfit Agriscience Private Limited, Amaze Healthcare Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Aaliya Younus Naik was appointed as Director on 13 May 2023. Ashutosh Suresh Gokhale was appointed as Director on 13 May 2023.
The registered office of Aspan Pharma is at Re A – 19 MIDC Res Zone, Near Dombivali Gymkhana, Kalyan, Maharashtra, India – 421201.
Aspan Pharma operates in the paper industry, in the paper and paper products segment.
Aspan Pharma can be reached at its registered office: Re A – 19 MIDC Res Zone, Near Dombivali Gymkhana, Kalyan, Maharashtra, India – 421201.
Aspan Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.